Leonard Braden Michael, listed in the filings under the role of Other at Outset Medical, Inc. (OM), bought $870,260 of company stock in transactions dated October 2nd, 2026.
The purchase came through two separate filings covering 244,909 shares. Reported prices ran from $3.53 to $3.8758, so the buying was spread across a narrow band rather than executed at a single print.
Outset Medical sells hemodialysis systems and sits in the Electromedical and Electrotherapeutic Apparatus group. The company carries a market capitalization of $77,068,368, which puts this purchase in the category of a buy that is large relative to the size of the issuer rather than a routine odd-lot add.
Size is the first thing to weigh. A 244,909 share block is a real position in a stock trading in the low single digits, and the fact that it arrived as two filings on the same transaction date suggests the shares were accumulated in pieces rather than crossed in one lot.
The other side of the ledger is the business itself. A market capitalization of $77,068,368 is small, and small-cap medical device names can move hard on single events such as reimbursement decisions, placement counts, or financing. An insider purchase tells you what one person did with their own money on one date. It does not tell you what the next quarter holds, and the filing itself gives no stated reason for the buy.
Price context matters here too. The reported range of $3.53 to $3.8758 sits below the last price of $4.10, so the stock has traded above the top of what this buyer paid. Anyone looking at the same setup today is not looking at the same entry.
Figures in this article come from Form 4 filings submitted to the Securities and Exchange Commission and reconciled against our own transaction tables, covering two filings with a transaction date of October 2nd, 2026.
Track every Form 4 filed at Outset Medical, Inc. (OM) → insiderbuying.com/companies/OM